new Interim Recommendations on Vaccination against Ebola Virus Disease from SAGE

SAGE
13 May 2019

Over the last four weeks, the Ebola outbreak in the Eastern Provinces of the Democratic Republic of Congo (DRC) has deteriorated with a large increase in the number of cases1. A major factor in this rise is an increase in critical security incidents that have dramatically affected the ability to identify, follow up and vaccinate contacts successfully. This context challenges the implementation of ring vaccination based on the identification of contacts and contacts of contacts, as recommended by SAGE in April 2017 and confirmed by SAGE during its April 2019 meeting. Further, a potential vaccine shortage may manifest in case the outbreak expands further and/or is prolonged.

ebola.png

SAGE deliberated on the following recommendations on implementation of novel strategies and adjusted dose regimes:

  1. Implementation of innovative operational strategies
  2. Revised vaccination strategy to adjust the target population for ring vaccination to include a second and third barrier of immunized individuals around each incident case.
  3. Alternative dosing for the rVSV-ZEBOV-GP vaccine
  4. Proposal to further adjust the protocol to incorporate alternative individual informed consent forms
  5. Implementation of a mass communication campaign
Documents to download

Related News & Events

  • Belgium
    SAGE

    New advisory report for the vaccination against Tick-Borne Encephalitis

    21.03.2019

    The Superior Health Council (SHC) received 2 requests for an advisory report by letter, on May 12 2017 from the Risk Management Group (FPS Health, Food Chain Safety and Environment) and on November 14 2018 from the federal Minister of Health. Both requests are treated in this advisory report.
     

    Read more
  • SAGE

    The latest WHO position paper on BCG vaccines

    28.02.2018

    This position paper replaces the 2004 WHO position paper on Bacille Calmette-Guérin (BCG) vaccine and the 2007 WHO revised BCG vaccination guidelines for infants at risk for human immunodeficiency virus (HIV) infection. It incorporates recent developments in the field of tuberculosis, provides revised guidance on the immunization of children infected with HIV, and re-emphasizes the importance of the BCG birth dose.

    Read more
  • Chile
    Functioning

    Chile's NITAG documents the results of the committee's evaluation

    02.07.2019

    In this article, we describe the structure, functioning and work processes of Chile’s NITAG (CAVEI) and assess its functionality, quality of work processes and outputs, and integration of the committee into the Ministry of Health policy process using the Assessment tool for National Immunization Technical Advisory Groups.

    Read more